InVirtuoLabs
InVirtuoLabs accelerates drug discovery by identifying and optimizing small-molecule candidates with AI and physics-based molecular simulations. The company combines multimodal machine learning, active learning, and generative chemistry models with physics-based molecular simulations to predict binding and optimize molecular properties. It operates as a drug discovery platform for biopharma and biotech, integrating with computational chemistry workflows to support candidate prioritization. The approach focuses on preclinical lead identification and optimization using scalable ML models and simulation pipelines.
InVirtuoLabs
InVirtuoLabs accelerates drug discovery by identifying and optimizing small-molecule candidates with AI and physics-based molecular simulations. The company combines multimodal machine learning, active learning, and generative chemistry models with physics-based molecular simulations to predict binding and optimize molecular properties. It operates as a drug discovery platform for biopharma and biotech, integrating with computational chemistry workflows to support candidate prioritization. The approach focuses on preclinical lead identification and optimization using scalable ML models and simulation pipelines.